USPTO serial 79433668
RACTHERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BELL,JUNA QUEEN
- Law office
- TMO LAW OFFICE 133
What this means
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
Need help with RACTHERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; stem cells for scientific purposes; stem cells, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; cell culture media for scientific and research purposes; cell culture reagents for scientific and research use; media for bacteriological cultures, other than for medical or veterinary purposes; biochemical reagents for bacteriological cultures, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical preparations for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; chemicals for use in biological or biotechnological product development; biological preparations for use in biological or biotechnological product development, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Biological tissue cultures for medical purposes or veterinary purposes; cells for medical purposes; living cells for medical purposes or veterinary purposes; stem cells for medical purposes or veterinary purposes; cell culture media for medical purposes or veterinary purposes; cell culture reagents for medical purposes or veterinary purposes; media for bacteriological cultures for medical purposes or veterinary purposes; reagents for bacteriological cultures for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; cellular function activating agents for medical purposes; diagnostic reagents for medical or veterinary use; diagnostic preparations for medical or veterinary purposes; biochemical preparations for medical or veterinary purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; enzymes for medical purposes | ACTIVE | — |
| 010 | Electroencephalographs; pulse meters; body composition monitors; physical exercise apparatus for medical purposes; tomographs for medical purposes; diagnostic apparatus for medical purposes for use in medical laboratories for testing damaged genes, cells and tissues in the human or animal body in order to determine the suitability of regenerative medicine, cell therapy, and gene therapy; MRI apparatus for medical purposes; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of damaged tissues or other tissue-based diagnostic testing, cytology and cell-based testing, and genetics or gene-based testing; medical diagnostic instruments for the analysis of body fluids, somatic cells, stem cells, genes and tissues; genetic testing apparatus for medical purposes; apparatus for the regeneration of stem cells for medical purposes; surgical apparatus and instruments; robotic exoskeleton suits for medical purposes; body rehabilitation apparatus for medical purposes; medical apparatus and instruments for use in supporting, holding, or manipulating surgical instruments intraoperatively, or observing affected areas for cell therapy or gene therapy procedures and structural parts and accessories in the nature of arm connecting component therefor; medical apparatus and instruments for use in supporting, holding, or manipulating surgical instruments, namely, robotic arms and retractor arms; medical apparatus and instruments for use in observing affected areas for cell therapy or gene therapy, namely, surgical microscope arms and surgical assistance system comprising imaging module, infrared sensors, and image display devices | ACTIVE | — |
| 042 | Testing, inspection, research or development of pharmaceuticals; providing information, advice and consultancy services relating to testing, inspection, research or development of pharmaceuticals; testing, inspection, research or development of regenerative medical products; providing information, advice and consultancy services relating to testing, inspection, research or development of regenerative medical products; medical and scientific research, namely, conducting clinical trials for others; testing, inspection or research of stem cells; providing information, advice and consultancy services relating to testing, inspection or research of stem cells; gene therapy research, and testing or inspection of gene therapy pharmaceuticals; providing information, advice and consultancy services relating to gene therapy research, and testing or inspection of gene therapy pharmaceuticals; testing, inspection or research of medicine in the field of gene therapy; providing information, advice and consultancy services relating to testing, inspection or research of medicine in the field of gene therapy; testing, inspection or research of regenerative medicine; providing information, advice and consultancy services relating to testing, inspection or research of regenerative medicine; testing, inspection or research of cells for medical use and medical technology in the field of cell therapy; providing information, advice and consultancy services relating to testing, inspection or research of cells for medical use and medical technology in the field of cell therapy; product testing and scientific research in the field of chemistry; product testing and scientific research in the field of biology; research and development of pharmaceuticals and regenerative medical products for others; research and development of new products for others; scientific research; scientific laboratory services; testing, inspection, research or development of medical apparatus and instruments; providing information, advice and consultancy services relating to testing, inspection, research or development of medical apparatus and instruments; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing information, advice and consultancy services relating to testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; software as a service (SaaS) services featuring software for use in data and database management; software as a service (SaaS) services featuring software for use in quality control, manufacturing process control, intraoperative adjustment in the operating room and management of transplantation procedures of cell therapy pharmaceuticals; platform as a service (PaaS) services featuring computer software platforms for use in data and database management; platform as a service (PaaS) services featuring computer software platforms for use in quality control, manufacturing process control, intraoperative adjustment in the operating room and management of transplantation procedures of cell therapy pharmaceuticals; server hosting; electronic data storage; providing temporary use of online non-downloadable software computer programs for use in data and database management; providing temporary use of online non-downloadable computer software programs for use in quality control, manufacturing process control, intraoperative adjustment in the operating room and management of transplantation procedures of cell therapy pharmaceuticals; computer system design; development of computer platforms; software engineering services for data processing; computer programming services; computer software design, computer programming, and maintenance of computer software; off-site data backup; recovery of computer data; computer security consultancy; telecommunication network security consultancy; information technology (IT) support services, namely troubleshooting of computer software problems | ACTIVE | — |
| 044 | Medical information services in relation to pharmaceuticals; medical information services in relation to gene therapy; medical information services in relation to regenerative medicine; medical analysis services relating to the treatment of persons and provision of medical information in relation to pharmaceuticals and regenerative medical products; provision of medical information containing clinical data of patients; medical analysis services relating to the treatment of persons and provision of medical information; stem cell bank services; human tissue bank services; cultured cell bank services for medical transplantation; medical screening; medical testing services; provision of health information; health counselling; health care; consulting services in the field of health; dietary and nutritional guidance; rental of medical apparatus and instruments; rental of medical equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RACTHERA Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RACTHERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 27, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 27, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 31, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |